相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Incidence and predictors of hyperkalemia in patients with heart failure
Akshay S. Desai et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure
Anna K. Y. Chan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure
Xiuren Gao et al.
JOURNAL OF CARDIAC FAILURE (2007)
Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction
P Di Pasquale et al.
AMERICAN HEART JOURNAL (2005)
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
SA Hunt et al.
CIRCULATION (2005)
Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure
B Pitt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001
FA Masoudi et al.
CIRCULATION (2005)
Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis
GC Fonarow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Spironolactone improves lung diffusion in chronic heart failure
P Agostoni et al.
EUROPEAN HEART JOURNAL (2005)
Usefulness of spironolactone in a specialized heart failure clinic
W Sligl et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Rates of hyperkalemia after publication of the randomized aldactone evaluation study
DN Juurlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system
BF Palmer
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure
PM Mottram et al.
CIRCULATION (2004)
The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist
KL Davis et al.
CLINICAL THERAPEUTICS (2003)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial
JJV McMurray et al.
LANCET (2003)
Effects of spironolactone and metoprolol on QT dispersion in heart failere
M Akbulut et al.
JAPANESE HEART JOURNAL (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure
M Cicoira et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure
T Tsutamoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction
MG Modena et al.
AMERICAN HEART JOURNAL (2001)
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure - Insights from the Randomized Aldactone Evaluation Study (RALES)
F Zannad et al.
CIRCULATION (2000)
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction:: a systematic overview of data from individual patients
MD Flather et al.
LANCET (2000)
分享论文
